| CPC A61N 1/36021 (2013.01) [A61N 1/36034 (2017.08); A61N 1/0456 (2013.01)] | 22 Claims |
|
1. A patient treatment unit comprising:
a probe stimulus generator circuit that, while in active operation, generates a treatment signal including a pulse train of direct current (DC) pulses having a pulse frequency, a pulse current from 0.1 milliAmperes (mA) to 8.9 mA for a defined range of load impedance, and a pulse voltage dependent on a variable supply voltage supplied to the probe stimulus generator circuit, the variable supply voltage providing a maximum pulse voltage of about 165 Volts of DC (VDC);
a pair of electrically conducting probes coupled to the probe stimulus generator circuit for conducting the treatment signal through a body of a human or animal patient, as the load impedance, via non-invasive contact with skin of the patient, the pair of electrically conducting probes each comprising a rounded hemispherical probe tip;
an adhesive surface configured to attach the rounded hemispherical probe tip of one of the pair of electrically conducting probes to the skin;
a mode control circuit configured to activate and deactivate a treatment mode of the patient treatment unit in response to operator input, wherein the treatment mode is characterized by the active operation of the probe stimulus generator circuit;
an intensity adjustment circuit configured to control the variable supply voltage to start at a predefined starting voltage for each activation of the treatment mode; and
a visual display unit configured to display an elapsed time of treatment by starting at each activation of the treatment mode and stopping at each corresponding deactivation of the treatment, the elapsed time of treatment being displayed in a minutes and seconds format.
|
|
5. A patient treatment unit for delivering non-invasive pulsed energy to living tissue, the patient treatment unit comprising:
a probe stimulus generator circuit configured to output, as a treatment signal, a sequence of direct current (DC) electrical pulses at a controlled pulse frequency and having a pulse voltage defined by a variable supply voltage of the probe stimulus generator circuit;
a primary conductor having an elongated body and a rounded hemispherical tip that is configured to contact a body of a human or animal, the primary conductor being electrically coupled to the probe stimulus generator circuit so as to receive the DC electrical pulses;
a secondary conductor having a rounded hemispherical probe tip and configured to contact the body and electrically coupled to the probe stimulus generator circuit to complete an electrical circuit with the primary conductor through the body;
an intensity adjustment circuit configured to control the variable supply voltage, including setting the variable supply voltage to a predefined starting voltage upon activation of the probe stimulus generator circuit; and
a first electronic timer display configured to display an elapsed time in a human-understandable form, starting from each activation of the probe stimulus generator circuit and running until a corresponding deactivation of the probe stimulus generator circuit;
wherein
at least one of the primary conductor and the secondary conductor includes a probe tip configured to be adhered to the body.
|
|
19. A method of treating inflammation or a wound in a patient, the method comprising:
applying a first probe and a second probe to living tissue of a patient in an area where inflammation or a wound is indicated, wherein the first probe is adhered to the tissue of the patient;
causing electrical energy to be delivered through the probes and into the tissue in the form of a treatment signal, the treatment signal including a pulse train of direct current (DC) pulses having
a pulse frequency,
a pulse current from 0.1 milliAmperes (mA) to 8.9 mA for a defined range of load impedance, and
a pulse voltage dependent on a variable supply voltage supplied to the probe stimulus generator circuit, the variable supply voltage providing a maximum pulse voltage of about 165 Volts of DC (VDC);
while maintaining the first probe adhered in place, moving the second probe along the living tissue of the patient in a direction along a body of the patient;
picking up the second probe and moving or applying the second probe to the same or a new location on the patient; and
repeating the picking up and moving or picking up and applying steps one or more times to treat the inflammation or wound on the patient,
wherein the first probe and the second probe each comprise a rounded hemispherical probe tip, and the first probe is configured to be adhered to skin of the patient.
|